Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


If wishes were horses, companies would IPO

This article was originally published in Scrip

Executive Summary

Chairing a debate on the attractiveness of biotech IPOs, co-hosted by One Nucleus, the Cambridge-London biotech network , and Scrip Intelligence, it was surprising to see how divergent the views of participants were. Even though the experienced venture capitalists in the room argued passionately at why they no longer considered the initial public offerings as a relevant ambition for their portfolio companies they were unable to convince an audience composed mainly of start-up entrepreneurs.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts